Actavis

Three Reasons Actavis Is Buying Warner Chilcott

Three Reasons Actavis Is Buying Warner Chilcott

Forbes

Actavis to buy Warner Chilcott in $8.5 bln deal

Actavis to buy Warner Chilcott in $8.5 bln deal

Reuters

IBD 50: Top 5 Medical Stocks Include Celgene, Actavis

IBD 50: Top 5 Medical Stocks Include Celgene, Actavis

Investors Business Daily

Novartis says no intention of pursuing Actavis, Bloomberg reports

Novartis says no intention of pursuing Actavis, Bloomberg reports

Yahoo/Fly on the Wall

Actavis Said to Have Spurned $15 Billion Offer From Mylan

Actavis Said to Have Spurned $15 Billion Offer From Mylan

Bloomberg

What Companies Will This FDA Decision Impact?

What Companies Will This FDA Decision Impact?

Wall St. Cheat Sheet

Warner Chilcott shares rise in premarket on optimism about potential combination with Actavis

Warner Chilcott shares rise in premarket on optimism about potential combination with Actavis

Yahoo/AP

Actavis Said to Be in Early Talks to Acquire Warner Chilcott

Actavis Said to Be in Early Talks to Acquire Warner Chilcott

Bloomberg

On verge of $13B merger, Valeant and Actavis stop talking

On verge of $13B merger, Valeant and Actavis stop talking

Fierce Pharma

Valeant Pharmaceuticals in Talks to Buy Actavis

Valeant Pharmaceuticals in Talks to Buy Actavis

Wall Street Journal